FDA Approves Insulet’s New OmniPod Diabetes Management System

FDA Approves Insulet’s New OmniPod Diabetes Management System   

Insulet has announced FDA approval of the new version of its new OmniPod insulin delivery system. The system comprises an insulin pump, which has been made 34% smaller and 25% lighter over its predecessor, and a Personal Diabetes Manager (PDM) glucometer that communicates wirelessly with the pump, and now calculates the insulin on board (IOB). The communication between the devices has been improved to allow them to talk over a distance of up to five feet (1.5 meters). For added safety, the pump now features a pink indicator on its top to indicate that the cannula has been deployed.